AAF and @gbgmc.bsky.social invite you to the Long-Acting PrEP & Key Populations Pre-Conference today Oct 14, 2025 - ahead of the 20th EACSconference.
@eacsociety.bsky.social
#AAF #EACS2025 #HIVPrevention #LongActingPrEP #EndHIV

Estimated impact of long-acting injectable PrEP in South Africa: a model comparison analysis.
Bansi-Matharu, Loveleen, Barnabas, Ruanne V et al.
Paper
Details
#LongActingPrEP #SouthAfricaHealth #ModelComparisonAnalysis

Colourful i-Base graphic. The main text reads: Gilead’s lenacapavir access. A start, but further access and price transparency needed. At the top is i-Base’s website address: I hyphen base dot info. At the bottom it says, subscribe by email. A smaller, tilted square graphic on the right, reads: HTB news. 2025. HIV treatment, prevention, access, and more. The colours used in the image are two shades of turquoise, grey-plum, dark azure, vivid crimson, dark purple, yellow, orange, dark blue, mustard, teal, red, royal blue, lilac and white.

The #GlobalFund plans for #lenacapavir #PrEP in selected countries:

i-base.info/htb/51697

But #HealthGAP calls for transparency on pricing: “ #Gilead’s lenacapavir-LA price secrecy violates our basic rights and will undermine #GlobalAccess.”

#HIVsky #HIV #HIVprevention #LongActingPrEP #PrEPaccess

The Power of Choice, Community and Courage at CAHR 2025 Reflections on my first full day in Halifax, where science met storytelling and boldness met belonging.

My first full day at CAHR 2025 in Halifax was filled with meaningful dialogue on choice, community and harm reduction.

I’ve captured the highlights in my latest blog post. Read it now on Substack
substack.com/@theaccident...

#HIVAdvocacy #HealthEquity #UequalsU #HarmReduction #LongActingPrEP